Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Katholieke Universiteit Leuven Fund for Scientific Research, Flanders, Belgium |
---|---|
Information provided by: | Katholieke Universiteit Leuven |
ClinicalTrials.gov Identifier: | NCT00620841 |
A retrospective analysis of the influence of gene polymorphisms on drug interactions between calcineurin-inhibitors and concomitant drugs in renal transplant patients.
Condition | Intervention |
---|---|
Renal Transplantation |
Other: genotyping |
Study Type: | Observational |
Study Design: | Cohort, Retrospective |
Official Title: | Gene Polymorphisms in Tacrolimus Drug Interactions in Renal Transplant Patients |
DNA samples
Enrollment: | 40 |
Study Start Date: | May 2007 |
Study Completion Date: | January 2008 |
Primary Completion Date: | January 2008 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
---|---|
A
Patients treated with tacrolimus and experiencing a drug interaction
|
Other: genotyping
Restriction fragment lenght polymorphisms
|
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Renal transplant recipients treated with a calcineurin-inhibitor
Inclusion Criteria:
Exclusion Criteria:
Belgium, Brabant | |
University Hospitals Leuven | |
Leuven, Brabant, Belgium, B-3000 |
Principal Investigator: | Dirk R Kuypers, MD, PhD | University Hospitals Leuven Belgium |
Responsible Party: | University Hospital Gasthuisberg ( Catholic University Leuven, University Hospitals ) |
Study ID Numbers: | DDI-001 |
Study First Received: | February 13, 2008 |
Last Updated: | February 21, 2008 |
ClinicalTrials.gov Identifier: | NCT00620841 History of Changes |
Health Authority: | Belgium: Institutional Review Board |
Tacrolimus Renal Transplantation genetic polymorphisms Drug drug interactions |
Immunologic Factors Tacrolimus Immunosuppressive Agents |
Immunologic Factors Physiological Effects of Drugs Tacrolimus Immunosuppressive Agents Pharmacologic Actions |